Evidence map›Paper›PMID 42840204›Full record

ArticleCancer communications (London, England)2026

GULP1 Fuels Resistance to PD-1 Blockade through Lipid-Mediated Metabolic Reprogramming of Tumor-Associated Macrophages in Gastric Cancer.

Zihao Zhang, Wenxin Xu, Kuan Yu, Anran Bao, Yifan Cao, Mincheng Yu, Qiang Yu, Yufei Zhao, Liang Gong, Peiyi Xie and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer communications (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zihao ZhangDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Wenxin XuDepartment of Hepatobiliary Surgery and Transplantation, Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Kuan YuDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Anran BaoDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Yifan CaoDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Mincheng YuDepartment of Colorectal Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Qiang YuDepartment of Hepatobiliary Surgery and Transplantation, Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Yufei ZhaoDepartment of Hepatobiliary Surgery and Transplantation, Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Liang GongDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Peiyi XieDepartment of Hepatobiliary Surgery and Transplantation, Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Zhenbin ShenDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Jing QinDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adaptor Proteins, Signal TransducingDrug Resistance, NeoplasmImmune Checkpoint InhibitorsStomach NeoplasmsTumor-Associated MacrophagesAnimalsCell Line, TumorHumansLipid MetabolismMetabolic ReprogrammingMiceProgrammed Cell Death 1 ReceptorTumor MicroenvironmentAdaptor Proteins, Signal TransducingImmune Checkpoint InhibitorsPDCD1 protein, humanProgrammed Cell Death 1 Receptor

Identifiers

PMID42840204
PMCPMC13639144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.